Open access
Aug 2026
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans
Aging biomarkers can potentially allow researchers to rapidly monitor the impact of an aging intervention without the need for decade-spanning trials. However, before the use of aging biomarkers, such as epigenetic clocks, as surrogate endpoints, their responsiveness to interventions that target aging must be tested. H...
R. Sehgal, Daniel S. Borrus, Jenel F. Armstrong et al.
· Nature Medicine · 1 citation